CAVCO INDUSTRIES, INC.

CVCO

CIK 0000278166 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-27) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$581M
↑+11.3% +$59Mvs FY2024 (Q4)
Operating Income
$55M
↓-14.7% -$9Mvs FY2024 (Q4)
Net Income
$44M
↓-22.0% -$12Mvs FY2024 (Q4)
Gross Profit
$136M
↑+4.6% +$6Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
58/100
  • Profitability
    48ROIC 14.7% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.00 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    97Asset Turnover 1.46x (1.0+ = capital-efficient)
  • Growth
    54Revenue YoY +11.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    50Op Margin 9.4% · trend +0.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CVCO's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing 3-yr CAGR was 7.7%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$327.12
Total enterprise IV
$2.70B
Diluted shares
0.01B
Terminal PV
$1.96B (72% of total)
Year-5 FCF
$231M
YearProjected FCFDiscounted PV
+1$170M$154M
+2$183M$151M
+3$198M$149M
+4$214M$146M
+5$231M$143M
Terminal$3.15B$1.96B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$33M
investment in PP&E
Stock buybacks (TTM)
$164M
share count reduction
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2025-12-27

latest filed snapshot
Total assets
$1.47B
everything owned
Total liabilities
$383M
everything owed
Stockholders' equity
$1.09B
shareholder claim

Recent performance · 63 quarters

Revenue↑+11.3% +$59M
$581M
Net Income↓-22.0% -$12M
$44M
Free Cash Flow↑+78.2% +$25M
$58M
Operating Margin↓-2.9pts
9.4%

Drill down